Just over a year after its first phase 3 trial of its Engensis gene therapy for painful diabetic peripheral neuropathy (DPN) bombed, Helixmith has started dosing patients in a new study.

Painful diabetic peripheral neuropathy (DPN) is associated with significantly lower quality of life (QoL), increased anxiety and depression, and potential socioeconomic impacts relative to painless ...

Since its establishment in 1935, Seattle University College of Nursing has prepared highly regarded and compassionate health care professionals who make a difference in the Pacific Northwest and ...

The protection of your personal data is at the heart of our concerns. BNP Paribas SA (Communication Groupe) ("We"), as a controller, through our various brands, including for example BNP Paribas, We ...